Acquired hypofibrinogenemia: current perspectives

References

• MosessonMWFibrinogen and fibrin structure and functionsJ Thromb Haemost2005381894190416102057
   PubMed Web of Science ®Google Scholar
• CollinsPWSolomonCSutorKTheoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrateBr J Anaesth2014113458559525064078
   PubMed Web of Science ®Google Scholar
• CunninghamMTBrandtJTLaposataMOlsonJDLaboratory diagnosis of dysfibrinogenemiaArch Pathol Lab Med2002126449950511900586
   PubMed Web of Science ®Google Scholar
• Manco-JohnsonMJDimicheleDCastamanGPharmacokinetics and safety of fibrinogen concentrateJ Thromb Haemost20097122064206919804533
   PubMed Web of Science ®Google Scholar
• IdrisSFHadjinicolaouAVSweeneyMWinthropCBalendranGBesserMThe efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemiaBr J Haematol2014166345846124725203
   PubMed Web of Science ®Google Scholar
• GrottkeOBraunschweigTHenzlerDCoburnMTolbaRRossaintREffects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injuryCrit Care2010142R6220398253
   PubMed Web of Science ®Google Scholar
• MackieIJKitchenSMachinSJLoweGDGuidelines on fibrinogen assaysBr J Haematol2003121339640412716361
   PubMed Web of Science ®Google Scholar
• MacfarlaneRGBiggsRA thrombin generation test; the application in haemophilia and thrombocytopeniaJ Clin Pathol1953613813034911
   PubMed Web of Science ®Google Scholar
• FaradayNFibrinogen concentrate and allogeneic blood transfusion in high-risk surgeryAnesthesiology201311817923249924
   PubMed Web of Science ®Google Scholar
• Hunault-BergerMChevallierPDelainMChanges in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL studyHaematologica200893101488149418728028
   PubMed Web of Science ®Google Scholar
• BeinartGDamonLThrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemiaAm J Hematol200477433133515551293
   PubMed Web of Science ®Google Scholar
• RodeghieroFCastamanGDiniEFibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulationThromb Res199057131382300923
   PubMed Web of Science ®Google Scholar
• LudlamCABennettBFoxKALoweGDReidAWGuidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in HaematologyBlood Coagul Fibrinolysis1995632732857654941
   PubMed Web of Science ®Google Scholar
• DearABrennanSOSheatMJFaedJGeorgePMAcquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chainHaematologica20079211e111e11718024387
   PubMed Web of Science ®Google Scholar
• HammarstenOUeber das Fibrinogen I. Erster AbschnittPfluegers Arch Ges Physiol187919563622
   Google Scholar
• OwenCAHistory of Blood CoagulationRoechester, MNMayo Clinic2001
   Google Scholar
• MackieIJKitchenSMachinSJLoweGDHaemostasis, Thrombosis Task Force of the British Committee for Standards in H. Guidelines on fibrinogen assaysBr J Haematol2003121339640412716361
   PubMed Web of Science ®Google Scholar
• ChitolieAMackieIJGrantDHamiltonJLMachinSMInaccuracy of the ‘derived’ fibrinogen measurementBlood Coagul Fibrinolysis1994569559577893932
   PubMed Web of Science ®Google Scholar
• BesserMWKleinAAThe coagulopathy of cardiopulmonary bypassCrit Rev Clin Lab Sci2010475–619721221391830
   PubMed Web of Science ®Google Scholar
• MacdonaldSBannisterNOrtmannEDetermination of fibrinogen level to guide replacement therapy in patients undergoing cardiopulmonary bypass with direct thrombin inhibitorsJ Thromb Haemost201311s3
   Google Scholar
• HansGABesserMWThe place of viscoelastic testing in clinical practiceBr J Haematol20161731374826818064
   PubMed Web of Science ®Google Scholar
• PonschabMVoelckelWPavelkaMSchlimpCJSchochlHEffect of coagulation factor concentrate administration on ROTEM(R) parameters in major traumaScand J Trauma Resusc Emerg Med2015238426514413
   PubMed Web of Science ®Google Scholar
• HarrJNMooreEEGhasabyanAFunctional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following traumaShock2013391454923247121
   PubMed Web of Science ®Google Scholar
• SolomonCFickenscherKOrmondeLRanucciMValidation of viscoelastic coagulation tests during cardiopulmonary bypass: commentJ Thromb Haemost201513122279228126332686
   PubMed Web of Science ®Google Scholar
• LevyJHWelsbyIGoodnoughLTFibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyTransfusion201454513891405 quiz 138824117955
   PubMed Web of Science ®Google Scholar
• HuntBJAllardSKeelingDA practical guideline for the haematological management of major haemorrhageBr J Haematol2015170678880326147359
   PubMed Web of Science ®Google Scholar
• KalinaUStohrHABickhardHRotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiencyBlood Coagul Fibrinolysis200819877778319002044
   PubMed Web of Science ®Google Scholar
• BesserMWOrtmannEKleinAAHaemostatic management of cardiac surgical haemorrhageAnaesthesia201570Suppl 18795e293125440401
   PubMed Web of Science ®Google Scholar
• MallaiahSBarclayPHarrodIChevannesCBhallaAIntroduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhageAnaesthesia201570216617525289791
   PubMed Web of Science ®Google Scholar
• Leal-NovalSRCasadoMArellano-OrdenVAdministration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator groupBMC Anesthesiol20141410925489274
   PubMed Web of Science ®Google Scholar
• PoolJGCryoprecipitate in the treatment of hemophiliaCalif Med19701132666718730395
   PubMedGoogle Scholar
• CohnEJOncleyJLStrongLEHughesWLArmstrongSHChemical, clinical, and immunological studies on the products of human plasma fractionation. I. the characterization of the protein fractions of human plasmaJ Clin Invest194423441743216695119
   PubMedGoogle Scholar
• YasunagaHRisk of authoritarianism: fibrinogen-transmitted hepatitis C in JapanLancet200737096042063206718083405
   PubMed Web of Science ®Google Scholar
• BruynseelsDSolomonCHallamACommentary on reconstituting fibrinogen concentrate to maintain blinding in a double-blind, randomized trial in an emergency settingJ Emerg Med2016501104107e10126508700
   PubMed Web of Science ®Google Scholar
• GalasFRde AlmeidaJPFukushimaJTHemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trialJ Thorac Cardiovasc Surg201414841647165524951020
   PubMed Web of Science ®Google Scholar
• IdrisSFHadjinicolaouAVSweeneyMWinthropCBalendranGBesserMIs the continued use of UK plasma sourced cryoprecipitate justified? Response to MakrisBr J Haematol2015168691091125270161
   PubMed Web of Science ®Google Scholar
• Costa-FilhoRHochleitnerGWendtMTeruyaASpahnDROver 50 years of fibrinogen concentrateClin Appl Thromb Hemost201622210911426294722
   PubMed Web of Science ®Google Scholar
• HannaJMKeenanJEWangHUse of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrestJ Thorac Cardiovasc Surg2016151237638226428473
   PubMed Web of Science ®Google Scholar
• WikkelsoAJEdwardsHMAfshariAPre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trialBr J Anaesth2015114462363325586727
   PubMed Web of Science ®Google Scholar
• TanakaKAEganKSzlamFTransfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusionTransfusion201454110911823718572
   PubMed Web of Science ®Google Scholar
• MartiniWZDubickMAFibrinogen concentrate administration inhibits endogenous fibrinogen synthesis in pigs after traumatic hemorrhageJ Trauma Acute Care Surg2015794540547 discussion 547–54826402526
   PubMed Web of Science ®Google Scholar
• BolligerDTanakaKAHaemostatic efficacy of fibrinogen concentrate: is it the threshold or the timing of therapy?Br J Anaesth2015115215816126041716
   PubMed Web of Science ®Google Scholar
• ZentaiCBraunschweigTSchnabelJRoseMRossaintRGrottkeOFibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma modelAnesthesiology2014121475376424866407
   PubMed Web of Science ®Google Scholar
• MartiniJMaischSPilshoferLStreifWMartiniWFriesDFibrinogen concentrate in dilutional coagulopathy: a dose study in pigsTransfusion201454114915723672536
   PubMed Web of Science ®Google Scholar
• Rahe-MeyerNSolomonCWinterhalterMThromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgeryJ Thorac Cardiovasc Surg2009138369470219698858
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceDetecting, Managing and Monitoring Haemostasis: Viscoelastometric Point-of-Care Testing (ROTEM, TEG and Sonoclot Systems)2014 Available from: https://www.nice.org.uk/guidance/dg13Accessed August 31, 2014
   Google Scholar
• AubronCReadeMCFraserJFCooperDJEfficacy and safety of fibrinogen concentrate in trauma patients – a systematic reviewJ Crit Care2014293471e41147724508201
   PubMed Web of Science ®Google Scholar
• WafaisadeALeferingRMaegeleMAdministration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at dischargeJ Trauma Acute Care Surg2013742387383 discussion 393–38523354229
   PubMed Web of Science ®Google Scholar